{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02811510",
            "orgStudyIdInfo": {
                "id": "1505015940.A"
            },
            "organization": {
                "fullName": "Yale University",
                "class": "OTHER"
            },
            "briefTitle": "Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I",
            "officialTitle": "Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I",
            "acronym": "THC-Gender-I",
            "therapeuticArea": [
                "Other"
            ],
            "study": "gender-related-differences-in-the-acute-effects-of-delta-tetrahydrocannabinol-in-healthy-humans-sub-study-i"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-06"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-06-02",
            "studyFirstSubmitQcDate": "2016-06-20",
            "studyFirstPostDateStruct": {
                "date": "2016-06-23",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-05-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mohini Ranganathan",
                "investigatorTitle": "Assistant Professor of Psychiatry",
                "investigatorAffiliation": "Yale University"
            },
            "leadSponsor": {
                "name": "Yale University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.",
            "detailedDescription": "To characterize the acute effects of oral Dronabinol (10 mg capsule) in women relative to men and to begin probing the mechanisms that may underlie gender differences."
        },
        "conditionsModule": {
            "conditions": [
                "Cannabis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "10 mg Dronabinol will be administered orally.",
                    "interventionNames": [
                        "Drug: Dronabinol"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo pill (no active cannabinoids).",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo pill (no active cannabinoids)",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Dronabinol",
                    "description": "10 mg capsule of Dronabinol will be administered orally.",
                    "armGroupLabels": [
                        "THC"
                    ],
                    "otherNames": [
                        "Delta-9-Tetrahydrocannabinol"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change from Baseline: Rewarding Effects measured by Visual Analog Scale (VAS)",
                    "description": "Subjective measure of THC induced \"high\"",
                    "timeFrame": "changes in \"high\" assessed over the following timepoints: baseline, +60, +80, +120, +180, +300 minutes after start of oral Dronabinol administration."
                },
                {
                    "measure": "Change from Baseline: Verbal Learning: Measured by Rey Auditory Verbal Learning Test (RAVLT)",
                    "description": "Measured as delay recall on the AVLT",
                    "timeFrame": "baseline and +80 minutes after start of oral Dronabinol administration."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* At least one lifetime exposure to cannabis\n* Good physical and mental health\n\nExclusion Criteria:\n\n* Cannabis naive individuals\n* Major current or recent stressors\n* Taking estrogen supplements or oral contraceptive pills (for women)\n* Sesame oil allergy",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Carly Hewes, BS",
                    "role": "CONTACT",
                    "phone": "(203)932-5711",
                    "phoneExt": "7411",
                    "email": "carly.hewes@yale.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine",
                    "status": "RECRUITING",
                    "city": "West Haven",
                    "state": "Connecticut",
                    "zip": "06516",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carly Hewes, BS",
                            "role": "CONTACT",
                            "phone": "203-932-5711",
                            "phoneExt": "7411",
                            "email": "carly.hewes@yale.edu"
                        },
                        {
                            "name": "Mohini Ranganathan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.27065,
                        "lon": -72.94705
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5449",
                    "name": "Marijuana Abuse",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013759",
                    "term": "Dronabinol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006213",
                    "term": "Hallucinogens"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000063386",
                    "term": "Cannabinoid Receptor Agonists"
                },
                {
                    "id": "D000063385",
                    "term": "Cannabinoid Receptor Modulators"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16527",
                    "name": "Dronabinol",
                    "asFound": "Paired",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9305",
                    "name": "Hallucinogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}